GTGermain Trugnan

Germain Trugnan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Germain Trugnan has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Agnes Gardet

    Sorbonne Universités, UPMC University Paris 06, École Normale Supérieure, PSL Research University, CNRS, INSERM U1157, APHP, Laboratoire des Biomolécules (LBM), Paris, France

    1 shared publication
  • Catherine Etchebest

    Université Paris Cité and Université de la Réunion, INSERM, EFS, BIGR U1134

    1 shared publication
  • Catherine Sapin

    UPMC University Paris 06, UMRS 538 “Trafic membranaire et signalisation dans les cellules épithéliales”, 27 rue de Chaligny, 75012 Paris, France

    1 shared publication
  • Jean Pierre Grill

    UPMC University Paris 06, UMRS 538 “Trafic membranaire et signalisation dans les cellules épithéliales”, 27 rue de Chaligny, 75012 Paris, France

    1 shared publication
  • Laurent Beaugerie

    UPMC University Paris 06, UMRS 538 “Trafic membranaire et signalisation dans les cellules épithéliales”, 27 rue de Chaligny, 75012 Paris, France

    1 shared publication
  • Loïc Jaffrelo

    UPMC University Paris 06, UMRS 538 “Trafic membranaire et signalisation dans les cellules épithéliales”, 27 rue de Chaligny, 75012 Paris, France

    1 shared publication

Latest Publications

  • The C Terminus of Rotavirus VP4 Protein Contains an Actin Binding Domain Which Requires Cooperation with the Coiled-Coil Domain for Actin Remodeling

    by Wilfried Condemine, Thibaut Eguether, Nathalie Couroussé, Catherine Etchebest, Agnes Gardet, Germain Trugnan, Serge Chwetzoff

    Rotaviruses are causal agents of acute infantile viral diarrhea. In intestinal cells, in vitro as well as in vivo , virus assembly and exit do not imply cell lysis but rely on an active process in which the cytoskeleton plays a major role. We describe here a novel molecular mechanism by which the rotavirus spike protein VP4 drives actin remodeling. This relies on the fact that VP4 occurs in different forms. Besides its structural function within the virion, a large proportion of VP4 is expressed as free protein. Here, we show that free VP4 possesses a functional actin-binding domain. This domain, in coordination with a coiled-coil domain, promotes actin cytoskeleton remodeling, thereby providing the capacity to destabilize the cell membrane and allow efficient rotavirus exit.


  • Open Access

    Rotavirus-Like Particles: A Novel Nanocarrier for the Gut

    by Naima G. Cortes-Perez, Catherine Sapin, Loïc Jaffrelo, Sabine Daou, Jean Pierre Grill, Philippe Langella, Philippe Seksik, Laurent Beaugerie, Serge Chwetzoff, Germain Trugnan

    The delivery of bioactive molecules directly to damaged tissues represents a technological challenge. We propose here a new system based on virus-like particles (VLP) from rotavirus, with a marked tropism for the gut to deliver bio-active molecules to intestinal cells. For this, nonreplicative VLP nanoparticles were constructed using a baculovirus expression system and used to deliver an exogenous biomolecule, the green fluorescent protein (GFP), into either MA104 cells or intestinal cells from healthy and 2,4,6-trinitrobenzene sulfonic acid (TNBS)-treated mice. Our results show that expression of rotavirus capsid proteins in baculovirus led to the auto assembly of VLP that display similar properties to rotavirus. In vitro experiments showed that VLP were able to enter into MA104 cells and deliver the reporter protein. Intragastric administration of fluorescent VLP in healthy and TNBS-treated mice resulted in the detection of GFP and viral proteins in intestinal samples. Our results demonstrate an efficient entry of non-replicative rotavirus VLP into the epithelial cell line MA104 and provide the first in vivo evidence of the potential of these nanoparticles as a promising safe candidate for drug delivery to intestinal cells.